Spark Therapeutics Inc $ 113.57 0 (0%)
Warning! GuruFocus has detected with ONCE. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for Spark Therapeutics Inc () from 2015 to Oct 25 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Spark Therapeutics stock (ONCE) PE ratio as of Oct 25 2020 is 0. More Details
Spark Therapeutics PE Ratio (TTM) Historical Data
View and export this data going back to 2015. Start your Free Trial
Spark Therapeutics PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare TSE:4974 NAS:GBT NAS:IMMU NAS:RARE NAS:CRSP XSWX:GALE SZSE:002821 XBRU:ARGX NAS:AKCA XKRX:006280 SZSE:300294 NYSE:EBS NAS:FOLD NAS:ANAB NAS:PBYI NYSE:XON NAS:ASND NAS:HALO ROCO:4147 NAS:DNLI
Address 3737 Market Street, Suite 1300, Philadelphia, PA, USA, 19104
Spark Therapeutics Inc is a biotechnology company with a focus on gene therapy and orphan disease treatment. The company has one business segment, Pharmaceuticals, which is principally engaged in utilizing gene therapy to develop products to aid patients suffering from debilitating diseases. Spark has a pipeline with products that target choroideremia, genetic blinding conditions or inherited retinal disease, and a product targeting hematologic disorders. The company earns the vast majority of its revenue in the United States.